Immediate Migration of Biopsy Clip Markers After Upright Digital Breast Tomosynthesis-Guided Vacuum-Assisted Core Biopsy

Teichgraeber, Davis C.; Martaindale, Sarah; Omofoye, Toma S.; Hess, Kenneth R.; Parikh, Jay R.; Whitman, Gary J.

doi:10.1016/j.acra.2019.03.022

Cited by 14 publications

(6 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Marker clip migration is an ongoing challenge following all mammographically guided biopsies and can make confirming that a COL has been accurately sampled particularly difficult. Our clip migration rate of 19% is comparable to the 38% reported by Teichgraeber et al 21 for tomosynthesis-guided vacuum-assisted core biopsy. While it would seem logical that performing biopsy using a horizontal rather than a vertical approach to the plane of compression should reduce the incidence of clip 'migration' due to less concertina effect, this has not been supported by Weaver et al 22 Two specific areas for improvement reported by patients were ensuring adequate local anaesthesia and provision of more pre-procedural information.…”

Section: Discussionsupporting

confidence: 84%

Stereotactic biopsy with contrast‐enhanced mammography: the initial Australian experience

Layden,

Sesnan,

Kessell

et al. 2024

J Med Imag Rad Onc

View full text Add to dashboard Cite

IntroductionContrast‐enhanced mammography (CEM) and MRI detect ‘contrast‐only’ lesions (COLs) occult on standard breast imaging (ultrasound and conventional mammography). Until recently, MRI was the only reliable method of biopsy. This study presents the first Australian experience with CEM‐guided biopsy (CEMBx) and the lessons learnt.MethodsA prospective audit of the first 15 consecutive patients who underwent CEMBx for COLs was performed. Indications for contrast imaging, patient and lesion characteristics, procedural details, radiation dose and pathology data were collected.ResultsThe 15 women were aged 37–81 years (mean 59 years). Indications for contrast imaging were problem solving (n = 3), moderate risk screening (n = 2), cancer staging (n = 9) and symptoms (n = 1). The COLs were non‐mass (n = 14), mass (n = 1) and an enhancing asymmetry (n = 1). For one patient, two lesions were sampled during the same event. All lesions enhanced and were successfully sampled followed by marker clip insertion. Most biopsies (87.5%) were performed with the breast in cranio‐caudal compression using a horizontal approach. Procedural duration ranged from 13 to 33 min (mean 22 min). Radiation dose was similar to standard stereotactic biopsy. Post‐biopsy hematomas occurred in three patients, none required intervention. Clip displacement occurred in three cases. Core biopsy histopathology results were benign (n = 8), malignant (n = 7) and a borderline breast lesion (BBL) (n = 1). Patient satisfaction rates were high. Imaging follow‐up is ongoing.ConclusionsCEMBx is a quick, safe and reliable alternative to MRIBx to sample COLs.

show abstract

Section: Discussionsupporting

confidence: 84%

Stereotactic biopsy with contrast‐enhanced mammography: the initial Australian experience

Layden,

Sesnan,

Kessell

et al. 2024

J Med Imag Rad Onc

View full text Add to dashboard Cite

show abstract

“…There was a similar frequency of clip migration > 1cm between DBTB vs PSBB (14% vs 13%). This migration frequency was lower than that reported Teichgraeber and colleagues who found a 38% clip migration frequency in patients undergoing tomosynthesis‐guided biopsy 19 . However, their definition of clip migration included any case with migration over 0.5cm from the target (vs > 1cm in our study) which likely accounts for the higher migration frequency.…”

Section: Discussioncontrasting

confidence: 73%

Transition to digital breast tomosynthesis‐guided biopsies: Results and complications compared to stereotactic biopsies

Weinfurtner

Carter

2020

Breast J

View full text Add to dashboard Cite

“…Despite the complexity in differentiating between the markers, the surgeon proceeded with successful removal of both. Some reports have demonstrated that the Magseed ® marker was not detectable if the tumor lesion was deeper than 6 cm (10)(11)(12)(13)(14)(15)(16)(17)(18)(19)(20)(21)(22). In our study, one Magseed ® was placed at a depth of 3.6 cm.…”

Section: Discussionmentioning

confidence: 58%

Clinical experience of the Magseed® magnetic marker to localize non-palpable breast lesions: a cohort study of 100 consecutive cases

Crèvecoeur¹,

Jossa²,

Bella³

et al. 2023

Gland Surg

View full text Add to dashboard Cite

Background: The aim of this study was to report on a cohort of 100 patients where the Magseed ® paramagnetic marker was used to localize non-palpable breast lesions.Methods: Data was collected from a cohort of 100 patients with non-palpable breast lesions, who underwent localization using the Magseed ® marker. This marker consists of a paramagnetic seed that can be seen on mammography or ultrasound and intraoperatively detected with the use of the Sentimag ® probe.The data were collected over a period of 23 months (May 2019 to April 2021).Results: All 111 seeds were successfully placed in the breasts of 100 patients under ultrasound or via stereotactic guidance. Eighty-nine seeds were inserted in single lesions or small microcalcification clusters in a single breast, 12 seeds were deployed to a bracket microcalcification clusters and 10 to help localize two tumors within the same breast. Most Magseed ® markers (88.3%) were placed in the center of the lesion (≤1 mm). The re-excision rate was 5%. All Magseed ® markers were successfully retrieved and no surgical complications were observed.Conclusions: This study reports our experience in a Belgian breast unit using the Magseed ® magnetic marker and it highlights the many advantages of the Magseed ® marker system. With this system, we successfully identified subclinical breast lesions and extended microcalcification clusters, targeting multiple sites within the same breast.

show abstract

Immediate Migration of Biopsy Clip Markers After Upright Digital Breast Tomosynthesis-Guided Vacuum-Assisted Core Biopsy

Cited by 14 publications

References 16 publications

Stereotactic biopsy with contrast‐enhanced mammography: the initial Australian experience

Stereotactic biopsy with contrast‐enhanced mammography: the initial Australian experience

Transition to digital breast tomosynthesis‐guided biopsies: Results and complications compared to stereotactic biopsies

Clinical experience of the Magseed® magnetic marker to localize non-palpable breast lesions: a cohort study of 100 consecutive cases

Contact Info

Product

Resources

About